People / Staff

Cinzia Emilia Lavarino

Search publications

Publications

  • Acosta S, Lavarino C, Paris R, Garcia I, de Torres C, Rodríguez E, Beleta H and Mora J.

    Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells

    BMC DEVELOPMENTAL BIOLOGY . 9: 12-12. Number of citations: 50

    [doi:10.1186/1471-213X-9-12]

  • Lavarino C, Cheung NK, Garcia I, Domenech G, de Torres C, Alaminos M, Rios J, Gerald WL, Kushner B, LaQuaglia M and Mora J.

    Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma

    BMC Cancer . 9: 44-44. Number of citations: 27

    [doi:10.1186/1471-2407-9-44]

  • Lavarino C, Garcia I, Mackintosh C, Cheung NK, Domenech G, Ríos J, Perez N, Rodríguez E, de Torres C, Gerald WL, Tuset E, Acosta S, Beleta H, de Alava E and Mora J.

    Differential expression of genes mapping to recurrently abnormal chromosomal regions characterize neuroblastic tumours with distinct ploidy status

    BMC MEDICAL GENOMICS . 1: 36-36. Number of citations: 11

    [doi:10.1186/1755-8794-1-36]

  • Mora J, Lavarino C, Alaminos M, Cheung NK, Ríos J, de Torres C, Illei P, Juan G and Gerald WL.

    Comprehensive analysis of tumoral DNA content reveals clonal ploidy heterogeneity as a marker with prognostic significance in locoregional neuroblastoma

    GENES CHROMOSOMES & CANCER . 46(4): 385-396. Number of citations: 7

    [doi:10.1002/gcc.20421]

  • Coma S, Noe V, Lavarino C, Adán J, Rivas M, López-Matas M, Pagan R, Mitjans F, Vilaró S, Piulats J and Ciudad CJ.

    Use of siRNAs and antisense oligonucleotides against survivin RNA to inhibit steps leading to tumor angiogenesis.

    Oligonucleotides . 14(2): 100-113. Number of citations: 56

    [doi:10.1089/1545457041526290]

  • Tamborini E, Della Torre G, Lavarino C, Azzarelli A, Carpinelli P, Pierotti MA and Pilotti S.

    Analysis of the molecular species generated by MDM2 gene amplification in liposarcomas.

    INTERNATIONAL JOURNAL OF CANCER . 92(6): 790-796. Number of citations: 43

    [doi:10.1002/ijc.1271]

  • Birindelli S, Perrone F, Oggionni M, Lavarino C, Pasini B, Vergani B, Ranzani GN, Pierotti MA and Pilotti S.

    Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors.

    LABORATORY INVESTIGATION . 81(6): 833-844. Number of citations: 91

    [doi:10.1038/labinvest.3780293]

  • Lavarino C, Pilotti S, Oggionni M, Gatti L, Perego P, Bresciani G, Pierotti MA, Scambia G, Ferrandina G, Fagotti A, Mangioni C, Lucchini V, Vecchione F, Bolis G, Scarfone G and Zunino F.

    p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma.

    JOURNAL OF CLINICAL ONCOLOGY . 18(23): 3936-3945. Number of citations: 124

    [doi:10.1200/JCO.2000.18.23.3936]

  • Butò S, Pierotti MA, Tamborini E, Della Torre G, Lavarino C, Rilke F and Pilotti S.

    Biochemical uncovering of mdm2/p53 complexes in liposarcomas parallels their immunohistochemical detection.

    DIAGN MOL PATHOL . 8(3): 125-130. Number of citations: 14

    [doi:10.1097/00019606-199909000-00004]

  • Di Palma S, Corletto V, Lavarino C, Birindelli S and Pilotti S.

    Unilateral aneuploid dedifferentiated acinic cell carcinoma associated with bilateral-low grade diploid acinic cell carcinoma of the parotid gland.

    VIRCHOWS ARCHIV . 434(4): 361-365. Number of citations: 39

    [doi:10.1007/s004280050353]